Tech billionaire Elon Musk announced the next-gen Neuralink chips. Plus, first trials for Blindsight augmentation are also on their way.

The firm has announced its readiness to implant a new device, Blindsight, into a human patient. The move comes as part of the company's broader mission to develop brain-computer interfaces (BCIs).

Elon Musk has set a bold new goal for Neuralink, his brain–computer interface company, saying implant surgeries could become almost fully automated as early as 2026. The announcement, shared in late ...